A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I/II Study of Dasatinib and Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
RAD001 Plus Bevacizumab in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Taxotere/Temodar/Cisplatin Study in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of ADI-PEG 20 in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tasisulam in Treating Participants With Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Melanoma Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2